You just read:

Helsinn Group and MEI Pharma Enter Strategic Agreement for the Development and Commercialization of Pracinostat for the Treatment of Acute Myeloid Leukemia and Other Hematologic Diseases

News provided by

MEI Pharma, Inc.

Aug 08, 2016, 08:00 ET